Increase Access to Medicines

We are proud to invest in innovation that helps answer the world's most significant health challenges. But we know that’s just the start of the conversation.

Our commitment to social impact also inspires how we work to expand access to our medicines and tackle complex global health challenges.

We’re making care more affordable in the United States, like launching programs so that anyone using Lilly insulin – regardless of their insurance status – is eligible to fill their monthly prescription for $35. And we’re also separately supporting efforts to improve access to quality health care around the world, furthering the goal of reaching as many patients with unmet needs, no matter where they live.

Reaching across industry boundaries, we support leading organizations in their work to reach more people and help them feel better in their daily lives. Our collective work benefits individual patients and the entire global health system.

Lilly 30x30

Globally, we’ve established a goal – Lilly 30x30 – to provide improved access to quality health care for 30 million people in resource-limited settings, annually, by 2030.

Lilly 30x30 is a company-wide effort and includes strategic work with external organizations and donations supporting nonprofit organizations.

We use a mix of pipeline development, programs, and philanthropy to improve health systems and concentrate on diseases where we have deep technical expertise, including diabetes, obesity, and cancer.